2024-11-01 2025-11-30 false Capium Accounts Production 1.1 SC827602 2024-11-01 2025-11-30 SC827602 bus:FullAccounts 2024-11-01 2025-11-30 SC827602 bus:FRS102 2024-11-01 2025-11-30 SC827602 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-11-30 SC827602 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-11-30 SC827602 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-11-30 SC827602 2024-11-01 2025-11-30 SC827602 2025-11-30 SC827602 bus:RegisteredOffice 2024-11-01 2025-11-30 SC827602 core:WithinOneYear 2025-11-30 SC827602 core:AfterOneYear 2025-11-30 SC827602 1 2024-11-01 2025-11-30 SC827602 bus:Director1 2024-11-01 2025-11-30 SC827602 bus:Director1 2025-11-30 SC827602 bus:Director2 2024-11-01 2025-11-30 SC827602 bus:Director2 2025-11-30 SC827602 2023-11-01 SC827602 2024-10-31 SC827602 bus:OrdinaryShareClass1 2024-11-01 2025-11-30 SC827602 bus:OrdinaryShareClass1 2025-11-30 SC827602 core:ComputerEquipment 2024-11-01 2025-11-30 SC827602 core:ComputerEquipment 2025-11-30 SC827602 core:ComputerEquipment 2024-10-31 SC827602 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-11-30 SC827602 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-10-31 SC827602 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 SC827602 core:CostValuation core:Non-currentFinancialInstruments 2024-10-31 SC827602 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 SC827602 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 SC827602 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 SC827602 core:Non-currentFinancialInstruments 2025-11-30 SC827602 core:Non-currentFinancialInstruments 2024-10-31 SC827602 core:ShareCapital 2025-11-30 SC827602 core:RetainedEarningsAccumulatedLosses 2025-11-30 SC827602 dpl:Item1 2024-11-01 SC827602 dpl:Item1 2025-11-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: SC827602
Scotland
ST MEDICAL CONSULTING LIMITED
Unaudited Financial Statements
Period of accounts Start date: 01 November 2024 End date: 30 November 2025

ST MEDICAL CONSULTING LIMITED Contents Page For the Period 01 November 2024 to 30 November 2025
Directors' Report | 1
Statement of Financial Position | 2
Notes to the Financial Statements | 3

ST MEDICAL CONSULTING LIMITED Directors' Report For the Period 01 November 2024 to 30 November 2025
Director's report and financial statements The directors present his/her/their annual report and the financial statements for the year ended 30 November 2025. Principal activities Principal activity of the company during the financial period was of medical consultants Directors The directors who served the company throughout the period were as follows:
Selina Tsim
Graeme Carroll
Statement of directors' responsibilities The directors are responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice. Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period. In preparing these financial statements, the directors are required to : select suitable accounting policies and then apply them consistently make judgements and accounting estimates that are reasonable and prudent state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The directors are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions This report was approved by the board and signed on its behalf by:
---------------------------------- Selina Tsim Director
Date approved: 17 July 2026 1

ST MEDICAL CONSULTING LIMITED Statement of Financial Position As at 30 November 2025
| Notes | 2025 £
--- | --- | ---
Fixed assets |  |
Tangible fixed assets | 3 | 1,014
|  | 1,014
Current assets |  |
Debtors | 4 | 8,049
Cash at bank and in hand |  | 14,239
|  | 22,288
Creditors: amount falling due within one year | 5 | (9,625)
Net current assets |  | 12,663
Total assets less current liabilities |  | 13,677
Provisions for liabilities | 6 | (193)
Net assets |  | 13,484
Capital and reserves |  |
Called up share capital | 7 | 100
Profit and loss account |  | 13,384
Shareholders' funds |  | 13,484
For the period ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the board of directors on 17 July 2026 and were signed on its behalf by:
------------------------------- Selina Tsim Director
2

ST MEDICAL CONSULTING LIMITED Notes to the Financial Statements For the Period 01 November 2024 to 30 November 2025
General Information ST MEDICAL CONSULTING LIMITED is a private company, limited by shares, registered in Scotland, registration number SC827602, registration address 1 Hill Crescent, Clarkston, G76 8DQ. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Deferred taxation Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Current and deferred tax assets and liabilities are not discounted. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment | 20% Reducing Balance
Provisions Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2. | Average number of employees Average number of employees during the period was 0.
3. | Tangible fixed assets
Cost or valuation | Computer Equipment |  | Total
| £ |  | £
At 01 November 2024 | - |  | -
Additions | 1,402 |  | 1,402
Disposals | (135) |  | (135)
At 30 November 2025 | 1,267 |  | 1,267
Depreciation
At 01 November 2024 | - |  | -
Charge for period | 253 |  | 253
On disposals | - |  | -
At 30 November 2025 | 253 |  | 253
Net book values
Closing balance as at 30 November 2025 | 1,014 |  | 1,014
Opening balance as at 01 November 2024 | - |  | -
4. | Debtors: amounts falling due within one year
| 2025 £
--- | ---
Trade Debtors | 8,049
| 8,049
5. | Creditors: amount falling due within one year
| 2025 £
--- | ---
Corporation Tax | 3,181
Accrued Expenses | 905
Directors' Current Accounts | 5,539
| 9,625
6. | Provisions for liabilities
| 2025 £
--- | ---
Deferred Tax | 193
| 193
7. | Share Capital
Allotted, called up and fully paid | 2025 £
--- | ---
100 Class A shares of £1.00 each | 100
| 100
3